Sperling Prostate Center

A First-of-its-Kind Vaccine to Prevent Prostate Cancer Recurrence

Prostate Cancer Vaccine | Sperling Prostate Center
Here is fantastic news for men who undergo an initial treatment for localized prostate cancer! In November, 2020 the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RV001, an investigational vaccine against prostate cancer recurrence after primary treatment. RV001 is manufactured by a Swedish pharmaceutical company called RhoVac. Let’s look at the keep reading

Artificial Intelligence in Medicine – Part 7: AI: As Good or Better Than Radiologists at Spotting Breast Cancer

Roughly 1 out of 8 women will be diagnosed with invasive breast cancer (BCa). Screening mammograms are able to detect very early lesions before symptoms, such as a palpable lump, occur. Early detection facilitates a diagnosis during a period when the probability of treatment success is highest. Standard 2D mammograms are the most used method keep reading

Artificial Intelligence in Medicine – Part 6: Impact of AI on the Doctor-Patient Relationship

“Physicians are valued for being brilliant diagnosticians and they now have more information and tools and technology at their disposal than ever before; yet patients don’t feel cared for, and doctors don’t feel like they can care for patients enough.”[i] Abraham Verghese, MD is hardly a household name, but among many doctors he is something keep reading
WordPress Image Lightbox